These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 10428792)
1. Defective beta-adrenergic receptor signaling precedes the development of dilated cardiomyopathy in transgenic mice with calsequestrin overexpression. Cho MC; Rapacciuolo A; Koch WJ; Kobayashi Y; Jones LR; Rockman HA J Biol Chem; 1999 Aug; 274(32):22251-6. PubMed ID: 10428792 [TBL] [Abstract][Full Text] [Related]
2. Modulation of SR Ca2+ release by the triadin-to-calsequestrin ratio in ventricular myocytes. Kučerová D; Baba HA; Bokník P; Fabritz L; Heinick A; Mát'uš M; Müller FU; Neumann J; Schmitz W; Kirchhefer U Am J Physiol Heart Circ Physiol; 2012 May; 302(10):H2008-17. PubMed ID: 22427521 [TBL] [Abstract][Full Text] [Related]
3. Altered function in atrium of transgenic mice overexpressing triadin 1. Kirchhefer U; Baba HA; Kobayashi YM; Jones LR; Schmitz W; Neumann J Am J Physiol Heart Circ Physiol; 2002 Oct; 283(4):H1334-43. PubMed ID: 12234783 [TBL] [Abstract][Full Text] [Related]
4. Complex formation between junctin, triadin, calsequestrin, and the ryanodine receptor. Proteins of the cardiac junctional sarcoplasmic reticulum membrane. Zhang L; Kelley J; Schmeisser G; Kobayashi YM; Jones LR J Biol Chem; 1997 Sep; 272(37):23389-97. PubMed ID: 9287354 [TBL] [Abstract][Full Text] [Related]
5. Transgenic mice with cardiac overexpression of alpha1B-adrenergic receptors. In vivo alpha1-adrenergic receptor-mediated regulation of beta-adrenergic signaling. Akhter SA; Milano CA; Shotwell KF; Cho MC; Rockman HA; Lefkowitz RJ; Koch WJ J Biol Chem; 1997 Aug; 272(34):21253-9. PubMed ID: 9261135 [TBL] [Abstract][Full Text] [Related]
6. Targeted inhibition of beta-adrenergic receptor kinase-1-associated phosphoinositide-3 kinase activity preserves beta-adrenergic receptor signaling and prolongs survival in heart failure induced by calsequestrin overexpression. Perrino C; Naga Prasad SV; Patel M; Wolf MJ; Rockman HA J Am Coll Cardiol; 2005 Jun; 45(11):1862-70. PubMed ID: 15936620 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of betaARK1 restores impaired biochemical beta-adrenergic receptor responsiveness but does not rescue CREB(A133) induced cardiomyopathy. Eckhart AD; Fentzke RC; Lepore J; Lang R; Lin H; Lefkowitz RJ; Koch WJ; Leiden JM J Mol Cell Cardiol; 2002 Jun; 34(6):669-77. PubMed ID: 12054854 [TBL] [Abstract][Full Text] [Related]
8. Overexpression of myocardial Gsalpha prevents full expression of catecholamine desensitization despite increased beta-adrenergic receptor kinase. Vatner DE; Asai K; Iwase M; Ishikawa Y; Wagner TE; Shannon RP; Homcy CJ; Vatner SF J Clin Invest; 1998 May; 101(9):1916-22. PubMed ID: 9576756 [TBL] [Abstract][Full Text] [Related]
9. Cardiac-specific overexpression of mouse cardiac calsequestrin is associated with depressed cardiovascular function and hypertrophy in transgenic mice. Sato Y; Ferguson DG; Sako H; Dorn GW; Kadambi VJ; Yatani A; Hoit BD; Walsh RA; Kranias EG J Biol Chem; 1998 Oct; 273(43):28470-7. PubMed ID: 9774476 [TBL] [Abstract][Full Text] [Related]
10. Interplay between the E2F pathway and β-adrenergic signaling in the pathological hypertrophic response of myocardium. Major JL; Salih M; Tuana BS J Mol Cell Cardiol; 2015 Jul; 84():179-90. PubMed ID: 25944088 [TBL] [Abstract][Full Text] [Related]
11. Cardiac hypertrophy and impaired relaxation in transgenic mice overexpressing triadin 1. Kirchhefer U; Neumann J; Baba HA; Begrow F; Kobayashi YM; Reinke U; Schmitz W; Jones LR J Biol Chem; 2001 Feb; 276(6):4142-9. PubMed ID: 11069905 [TBL] [Abstract][Full Text] [Related]
15. Transgenic overexpression of the Ca2+-binding protein S100A1 in the heart leads to increased in vivo myocardial contractile performance. Most P; Remppis A; Pleger ST; Löffler E; Ehlermann P; Bernotat J; Kleuss C; Heierhorst J; Ruiz P; Witt H; Karczewski P; Mao L; Rockman HA; Duncan SJ; Katus HA; Koch WJ J Biol Chem; 2003 Sep; 278(36):33809-17. PubMed ID: 12777394 [TBL] [Abstract][Full Text] [Related]
16. Early impairment of calcium handling and altered expression of junctin in hearts of mice overexpressing the beta1-adrenergic receptor. Engelhardt S; Boknik P; Keller U; Neumann J; Lohse MJ; Hein L FASEB J; 2001 Dec; 15(14):2718-20. PubMed ID: 11606476 [TBL] [Abstract][Full Text] [Related]
17. Transgenic triadin 1 overexpression alters SR Ca2+ handling and leads to a blunted contractile response to beta-adrenergic agonists. Kirchhefer U; Jones LR; Begrow F; Boknik P; Hein L; Lohse MJ; Riemann B; Schmitz W; Stypmann J; Neumann J Cardiovasc Res; 2004 Apr; 62(1):122-34. PubMed ID: 15023559 [TBL] [Abstract][Full Text] [Related]
18. Cardiac beta ARK1 inhibition prolongs survival and augments beta blocker therapy in a mouse model of severe heart failure. Harding VB; Jones LR; Lefkowitz RJ; Koch WJ; Rockman HA Proc Natl Acad Sci U S A; 2001 May; 98(10):5809-14. PubMed ID: 11331748 [TBL] [Abstract][Full Text] [Related]
19. Cellular and functional defects in a mouse model of heart failure. Esposito G; Santana LF; Dilly K; Cruz JD; Mao L; Lederer WJ; Rockman HA Am J Physiol Heart Circ Physiol; 2000 Dec; 279(6):H3101-12. PubMed ID: 11087268 [TBL] [Abstract][Full Text] [Related]